Lung, Colorectal, Melanoma, Breast, Ovarian, Brain, Multiple Myeloma, and Other Cancers


For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer.

Read more about 18F-FDG


18F-Pylarify (PSMA) & 68Ga-illuccix (PSMA)

Indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer:

  • With suspected metastasis who are candidates for initial definitive therapy.
  • With suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.
  • For selection of patients with metastatic prostate cancer, for whom lutetium Lu 177 vipivotide tetraxetan PSMA-directed therapy is indicated.

Read more about 18F-Pylarify

Read more about 68Ga-illuccix



Amino acid imaging agent indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment.

Read more about 18F-Axumin


68Ga-NetSpot (DOTATATE) & 64Cu-Detectnet (DOTATATE)

Indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adults.

Read more about 68Ga-NetSpot

Read more about 64Cu-Detectnet



Neuraceq (18F-florbetaben), Amyvid (18F-florbetapir), & Vizamyl (18F-flutemetamol)

Used to estimate β-amyloid neuritic plaque density in adult patients who have been diagnosed with mild with cognitive impairment or mild Alzheimer’s disease dementia.

Read more about Neuraceq (18F-florbetaben)‍

Read more about Amyvid (18F-florbetapir)

Read more about Vizamyl (18F-flutemetamol)

Still Have A Question?

Please don't hesitate to get in touch!